Losartan: Reduces Ascites, but induces Cancer? Again Some Stupid Statements from PNAS- Proceedings of the National Academy of Science of USA!

Abstract

The main purpose of the analyzes carried out by the colleagues in an recently published paper in PNAS-USA [Proceedings of the National Academy of Science of the United States of America) is focused 1) on the one hand on the in vitro effect of Losartan in murine ovarian carcinoma model, demonstrating that the adjuvant effect of losartan should be definitely synergistic with regard to the parallel-induced / or ongoing chemotherapy, and on the other hand 2) in addition, that malignant ascites in retrospectively observed patient group seems to be also reduced [1].